Timothy T. Goodnow
Known title: President and CEOCIK: 0001667588
Timothy T. Goodnow's purchase track record
How the stock did after each of Timothy T. Goodnow's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since December 10, 2024
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+54.4%
3 months: +27.3%
Beat the S&P 500
67%
median +39.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/13/2026 | SENS | $100K | +27.3% | +54.4% | +15.4% |
| 11/7/2025 | SENS | $101K | +23.6% | -16.3% | +10.0% |
| 12/10/2024 | SENS | $98K | +94.8% | +67.2% | +0.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SENS | ▼ Sell | Tax Withholding | 32,598 | $234K | 6/15/2026 | View on chart |
| SENS | ▲ Buy | Grant | 553,701 | $0 | 5/19/2026 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 28,598 | $166K | 5/15/2026 | View on chart |
| SENS | ▲ Buy | Open Market | 17,225 | $100K | 3/13/2026 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 27,067 | $169K | 11/15/2025 | View on chart |
| SENS | ▲ Buy | Open Market | 17,210 | $101K | 11/7/2025 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 79,646 | $41K | 6/16/2025 | View on chart |
| SENS | ▲ Buy | Grant | 2,025,956 | $0 | 5/23/2025 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 379,164 | $209K | 5/15/2025 | View on chart |
| SENS | ▲ Buy | Open Market | 315,000 | $98K | 12/10/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 632,166 | $177K | 11/15/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 275,206 | $107K | 6/15/2024 | View on chart |
| SENS | ▲ Buy | Grant | 4,553,551 | $0 | 5/23/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 359,114 | $180K | 5/15/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 591,945 | $361K | 11/15/2023 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 187,498 | $144K | 6/15/2023 | View on chart |
| SENS | ▲ Buy | Grant | 3,136,023 | $0 | 5/15/2023 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 481,127 | $356K | 5/15/2023 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 404,545 | $506K | 11/15/2022 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 105,219 | $102K | 6/15/2022 | View on chart |
| SENS | ▲ Buy | Grant | 1,762,932 | $0 | 5/26/2022 | View on chart |
| SENS | ▲ Buy | Grant | 139,000 | $0 | 5/26/2022 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 297,117 | $336K | 5/16/2022 | View on chart |
| SENS | ▼ Sell | Open Market | 464,390 | $1.1M | 2/11/2022 | View on chart |
| SENS | ▲ Buy | Grant | 673,268 | $0 | 2/10/2022 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 297,995 | $1.1M | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Beta Bionics and Senseonics announce iLet-Eversense 365 integration
Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.
Beta Bionics and Senseonics announce iLet-Eversense 365 integration. Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.